搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Medpage Today on MSN
1 天
GLP-1 Agents and Suicide: Making Sense of 2024's Mixed Data
Not long after the FDA wrapped its preliminary investigation of GLP-1 receptor agonists and suicidal thoughts or actions, the ...
The Wall Street Journal on MSN
13 天
GSK’s Cancer Drug Jemperli Moves a Step Closer to European Marketing Permission
In one of the final steps before a marketing authorization decision by the European Medicines Agency, it recommended ...
2 天
Anavex Life Sciences: Jumping In On Time Ahead Of An Early Alzheimer's Decision
Anavex Life Sciences' ANAVEX 2-73 shows promise in treating Alzheimer's, with strong efficacy in slowing cognitive and ...
News Medical on MSN
1 天
Faricimab lacks proof of added benefit over comparator therapies for macular edema
Since July 2024, faricimab has also been approved in Europe for the treatment of visual impairment due to macular oedema ...
3 天
on MSN
Elon Musk Shares Christmas Weight-Loss Post: 'Ozempic Santa'
Elon Musk has admitted to taking a weight-loss drug in a Christmas Day post on X, formerly Twitter, as he shared a picture of ...
12 天
on MSN
European agency endorses approval of Biocon Biologics’ biosimilar Ustekinumab
BENGALURU: Biocon Biologics, a biosimilars company and subsidiary of Biocon, has announced that the European Medicines Agency ...
3 天
AstraZeneca Withdraws Lung Cancer Drug Application in EU
The latest announcement is out from AstraZeneca ( (AZN) ).
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈